Mitsubishi Tanabe Pharma America to Showcase New Research Findings in ALS at 2025 MDA Clinical and Scientific Conference
Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of eleven abstracts covering research in amyotrophic lateral sclerosis (ALS) at the 2025 Muscular Dystrophy Association ...
Reuters1mon
Bain to buy Japan's Mitsubishi Tanabe Pharma for $3.4 billion
TOKYO, Feb 7 (Reuters) - U.S. private equity firm Bain Capital has bought Mitsubishi Tanabe Pharma in a deal worth 510 billion yen ($3.4 billion), saying it was encouraged by prospects of ...
The Victoria Advocate1mon
Mitsubishi Tanabe Pharma America Announces Real-World Data Analysis of Disease Progression with RADICAVA® (edaravone) in ALS
You have permission to edit this article. Edit Close Activate Subscribe My Account Logout Login/Register ...
MedCity News1mon
Mitsubishi Tanabe Pharma
Bain Capital’s buyout of Mitsubishi Tanabe Pharma brings a company with a drug portfolio and pipeline in areas such as immunology, central nervous system disorders, and metabolic disease.
Business Wire1mon
Bain Capital to Acquire Mitsubishi Tanabe Pharma Corporation
TOKYO & BOSTON--(BUSINESS WIRE)--Bain Capital, a leading global private investment firm, today announced it has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation ...
The Business Times11d
Blackstone buys Japan drug trial firm, adding to private equity health deals
BLACKSTONE is buying a company that helps drugmakers run clinical trials in Japan, adding to growing interest from private ...
Morningstar2d
Mitsubishi Tanabe Pharma America to Showcase New Research Findings in ALS at 2025 MDA Clinical and Scientific Conference
JERSEY CITY, N.J., March 12, 2025 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of eleven abstracts covering research in amyotrophic lateral ...